1. PI3K/Akt/mTOR Autophagy
  2. PI3K Autophagy
  3. 740 Y-P TFA

740 Y-P TFA  (Synonyms: 740YPDGFR TFA; PDGFR 740Y-P TFA)

Cat. No.: HY-P0175A
Handling Instructions Technical Support

740 Y-P TFA is a potent and cell-permeable PI3K activator. 740 Y-P TFA readily binds GST fusion proteins containing both the N- and C- terminal SH2 domains of p85 but fails to bind GST alone.

For research use only. We do not sell to patients.

Custom Peptide Synthesis

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other In-stock Forms of 740 Y-P TFA:

Other Forms of 740 Y-P TFA:

Top Publications Citing Use of Products

241 Publications Citing Use of MCE 740 Y-P TFA

WB

    740 Y-P TFA purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Apr;12(13):e2410032.  [Abstract]

    Protein expression and quantification of SGLT1, GLUT2, p-PI3K, p-AKT, p-S6K1, and p-eIF4B were performed. GAPDH was used to normalize the data. 740Y-P (30 μM; 24 h) was an activator of the PI3K/Akt signaling pathway.

    740 Y-P TFA purchased from MedChemExpress. Usage Cited in: Theranostics. 2024 Jul 8;14(11):4278-4296.  [Abstract]

    Western blotting was used to measure p-PI3K/PI3K, p-AKT/AKT, and p-mTOR/mTOR expression in MODE-K cells incubated with 740 Y-P (25 μg/mL; 24 h).

    740 Y-P TFA purchased from MedChemExpress. Usage Cited in: Exp Mol Med. 2023 May;55(5):939-951.  [Abstract]

    Western blot showing PI3K, AKT, p-AKT, GPX4, ACSL4, TFR1, and SLC7A11 in the tissue samples of ApoE−/− mice infused with saline or Ang II, with or without 740 Y-P (10 mg/kg/d) treatment. n = 3 in each group.

    740 Y-P TFA purchased from MedChemExpress. Usage Cited in: J Exp Clin Cancer Res. 2020 Jun 30;39(1):123.  [Abstract]

    Protein expression levels of p-AktSer473, p-mTORSer2448 with or without 740Y-P treatment are measured by Western blotting. Pretreatment with 740Y-P (PI3K agonist) inhibits downregulation of p-AktSer473 and p-mTORSer2448 expression induced by overexpression of BDH2.

    740 Y-P TFA purchased from MedChemExpress. Usage Cited in: Acta Biomater. 2018 Nov:81:278-292.  [Abstract]

    PC12 cells are pretreated with 740-YP (30 μM), or SC79 (13.7 μM), or 3BDO (100 μM) for 1 h, and for the duration of GO (50 μg/mL) incubation for 24 h. LC3 turnover is detected by western blotting.
    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    740 Y-P TFA is a potent and cell-permeable PI3K activator. 740 Y-P TFA readily binds GST fusion proteins containing both the N- and C- terminal SH2 domains of p85 but fails to bind GST alone[1].

    In Vitro

    740 Y-P TFA (50 μg/ml; 48 hours) specificly stimulates mitogenesis in medium is better than EGF or FGF at stimulating entry into S-phase, it shows the percentage of cells in S-phase for 48.3% in C2 cells. Additionally, LY294002 or wortmannin potently inhibits the mitogenic response stimulated by the 740 Y-P TFA peptide[1].
    740 Y-P TFA (1 μg/mL) stimulates mitogenesis at the lowest concentration tested. The peptide stimulates mitogenesis in both the presence and absence of serum (0.5%), and in the former instance a maximal response observed at 50 μg/mL. 740Y-P to stimulate mitogenesis is highly specific and not a general feature of a cell permeable SH2 domain binding peptides[1].
    740 Y-P TFA (30 μM; 24 hours) remarkably inhibits the level of LC3-II/LC3-I in GO-induced PC12 cells[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Western Blot Analysis[2]

    Cell Line: PC12 cells
    Concentration: 30 μM
    Incubation Time: 24 hours
    Result: Inhibited the protein expression of LC3-II.
    Molecular Weight

    3270.70 (free acid)

    Formula

    C141H222N43O39PS3.xC2HF3O2

    Sequence

    Arg-Gln-Ile-Lys-Ile-Trp-Phe-Gln-Asn-Arg-Arg-Met-Lys-Trp-Lys-Lys-Ser-Asp-Gly-Gly-{Tyr(PO2)}-Met-Asp-Met-Ser

    Sequence Shortening

    RQIKIWFQNRRMKWKKSDGG-{PO2Y}-MDMS

    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage

    Please store the product under the recommended conditions in the Certificate of Analysis.

    Purity & Documentation
    References
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass   Concentration   Volume   Molecular Weight *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    740 Y-P TFA
    Cat. No.:
    HY-P0175A
    Quantity:
    MCE Japan Authorized Agent: